Vascular Solutions’ Vari-Lase
This article was originally published in The Gray Sheet
Endovenous laser firm will limit marketing of varicose vein therapy in the second quarter, before full direct U.S. sales force commercialization in Q3, following 510(k) clearance slightly ahead of schedule. In the second half of 2003, Vascular Solutions expects to introduce its D-Stat Dry hemostatic bandage for control of surface bleeding in interventional procedures and Radial for bleeding control following radial artery catheterizations, as well as the Pronto extraction catheter...
You may also be interested in...
The Environmental Working Group and Scientific Analytical Institute say inadequate testing of talc-containing personal-care products is to blame for findings of asbestos in cosmetics, including three of 21 powder-based cosmetics SAI analyzed at EWG’s request. They continue to push for updated testing standards that include electron microscopy as a core component.
Commissioner Hahn’s tweet announcing a return to inspections, while not a new policy, may be signal that FDA understands sponsor concerns with the agency’s limited ability to conduct onsite inspections. Effort may be aimed at reassuring industry even as CRLs related to manufacturing increase.
Rushed final rule seeking to impose draconian cuts on drug reimbursement rates in the Medicare Part B program is certain to face legal and political obstacles. But the data included on international price benchmarks will still have an impact.